TuisSHTDY • OTCMKTS
add
Sinopharm Group ADR
Vorige sluiting
$11,75
Dagwisseling
$11,66 - $11,77
Jaarwisseling
$10,13 - $16,31
Markkapitalisasie
58,29 mjd HKD
Gemiddelde volume
12,89 k
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (CNY) | Mrt. 2025info | J/J-verandering |
|---|---|---|
Inkomste | 141,66 mjd | -3,81% |
Bedryfskoste | 6,72 mjd | -6,59% |
Netto inkomste | 1,46 mjd | 2,59% |
Netto winsgrens | 1,03 | 7,29% |
Wins per aandeel | — | — |
EBITDA | 3,70 mjd | -5,19% |
Effektiewe belastingkoers | 23,38% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (CNY) | Mrt. 2025info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 45,36 mjd | -32,44% |
Totale bates | 415,08 mjd | — |
Totale aanspreeklikheid | 285,93 mjd | — |
Totale ekwiteit | 129,16 mjd | — |
Uitstaande aandele | 3,12 mjd | — |
Prys om te bespreek | 0,46 | — |
Opbrengs op bates | 1,96% | — |
Opbrengs op kapitaal | 3,85% | — |
Kontantvloei
Netto kontantverandering
| (CNY) | Mrt. 2025info | J/J-verandering |
|---|---|---|
Netto inkomste | 1,46 mjd | 2,59% |
Kontant van bedrywe | -34,28 mjd | 27,81% |
Kontant van beleggings | 617,49 m | 141,09% |
Kontant van finansiering | 12,88 mjd | -41,88% |
Netto kontantverandering | -20,78 mjd | 17,10% |
Beskikbare kontantvloei | -14,13 mjd | — |
Meer oor
Sinopharm Group Co., Ltd. is a Chinese pharmaceutical company. The parent company of Sinopharm Group was Sinopharm Industrial Investment, a 51–49 joint venture of state-owned enterprise China National Pharmaceutical Group and civilian-run enterprise Fosun Pharmaceutical.
Its H shares were listed on the Hong Kong Stock Exchange in 2009, with its IPO price of HK$16 per share. Sinopharm Group's subsidiary Sinopharm CNMC and Sinopharm Accord served as the A share counterpart of the company. However, the A share of Sinopharm Group itself was unlisted.
Sinopharm Group was ranked 829th in 2016 Forbes Global 2000 list. Wikipedia
Gestig
2003
Webwerf
Werknemers
108 217
